Umbralisib

Generic Name
Umbralisib
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C31H24F3N5O3
CAS Number
1532533-67-7
Unique Ingredient Identifier
38073MQB2A
Background

Marginal zone lymphoma is a rare, slowly progressing type of non-Hodgkin lymphoma initially treated with rituximab (an anti-CD20 drug), either alone or in combination with chemotherapy. Unfortunately, many patients experience a relapse or develop resistance to these drugs. Treatment options then become limited, and alternate treatments for the lymphoma are r...

Indication

Umbralisib does not have any approved therapeutic indications.

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath